Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PFKP is a prospective prognostic, diagnostic, immunological and drug sensitivity predictor across pan-cancer

13 Oct 2023

Abstract excerpt

Phosphofructokinase, platelet (PFKP) is a rate-limiting enzyme of glycolysis that plays a decisive role in various human physio-pathological processes. PFKP has been reported to have multiple functions in different cancer types, including lung cancer and breast cancer. However, no systematic pancancer analysis of PFKP has been performed; this type of analysis could elucidate the clinical value of PFKP in terms of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Lipids, and Metabolism
Share to Epigenetics and DNA Methylation
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37833332
DOI: 10.1038/s41598-023-43982-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PFKP is a prospective prognostic, diagnostic, immunological and drug sensitivity predictor across pan-cancerPMID 37833332Read ↗

Glycolysis rate-limiting enzyme PFKP: A pan-cancer predictor for prognostic significant, immunological correlation, and drug sensitivity predictionSemantic proximity Read ↗

6-phosphofructo-2-kinase as therapeutic targets in cancer based on an integrated pan-cancer study6-phosphofructo-2-kinase as therapeutic targets in cancer based on an integrated pan-cancer studySemantic proximity Read ↗

Systematic pan-cancer analysis identifies 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) as a biomarker of tumor invasion and metastasis, immunity, and prognosisSemantic proximity Read ↗

Phosphofructokinase-1 in Cancer: A Promising Target for Diagnosis and TherapySemantic proximity Read ↗

PFKP Accelerates Malignant Features in Breast CancerSemantic proximity Read ↗

Systematic Analysis Uncovers Associations of PGK1 with Prognosis and Immunological Characteristics in Breast Cancer.Semantic proximity Read ↗

Prognosis and Immunological Characteristics of PGK1 in Lung Adenocarcinoma: A Systematic AnalysisSemantic proximity Read ↗

Identification of a glycolysis-related gene signature for predicting pancreatic cancer survivalSemantic proximity Read ↗

PKM2 modulates chemotherapy sensitivity by regulating autophagy and predicts the prognosis and immunity in pancancerSemantic proximity Read ↗

Comprehensive Analysis for Anti-Cancer Target-Indication Prioritization of Placental Growth Factor Inhibitor (PGF) by Use of Omics and Patient Survival DataSemantic proximity Read ↗

Pan-Cancer analysis of clinical significance and associated molecular features of glycolysisSemantic proximity Read ↗

Pan-cancer comprehensive analysis: The role of important PTK family genes in cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.